Nivata IPO Market Data
Sai Urja Indo Ventures
IPO GMP & Details
Check Sai Urja Indo Ventures IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.
At a glance
Sai Urja Indo Ventures IPO details
Unofficial market context
Sai Urja Indo Ventures IPO GMP trend
The chart shows recent GMP movement over time. GMP is unofficial and should not be treated as a listing-price forecast or recommendation.
Latest chart observation+₹10
Change across recorded history+₹10
Recorded observations4
Current GMP reference price₹123
+₹10₹0
1 Oct2 Oct
| Observation | GMP | Change | Reference price |
|---|---|---|---|
| 2 Oct 2026, 2:25 PM | +₹10 | +₹2 | ₹123 |
| 2 Oct 2026, 11:35 AM | +₹8 | ₹0 | ₹121 |
| 1 Oct 2026, 11:29 PM | +₹8 | +₹8 | ₹121 |
| 1 Oct 2026, 2:32 PM | ₹0 | — | ₹113 |
Issue schedule & market details
Sai Urja Indo Ventures IPO key data
These are structured market-data fields. Missing values are left blank rather than estimated.
Issue typeSME
ExchangeBSE SME
Price band₹107 – ₹113
Lot size1,200 shares
Issue size₹24.95 Cr
Open date25 Sep 2026
Close date29 Sep 2026
Listing date5 Oct 2026
Overall subscription4.43× subscribed
Last recorded GMP+₹10
GMP reference price₹123
Quick facts
Sai Urja Indo Ventures IPO FAQs
When does the Sai Urja Indo Ventures IPO open and close?
The opening date is 25 Sep 2026. The closing date is 29 Sep 2026.
When is the Sai Urja Indo Ventures IPO listing date?
The currently recorded listing date is 5 Oct 2026. The timetable can change if the issue schedule is revised.
What is the Sai Urja Indo Ventures IPO price band?
The currently recorded price band is ₹107 – ₹113.
What is the Sai Urja Indo Ventures IPO lot size?
The recorded lot size is 1,200 shares. Review the official issue terms before applying.
What is the Sai Urja Indo Ventures IPO subscription?
Nivata currently records overall issue subscription at 4.43 times. This is not an allotment probability.
This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.